INTIMA BIOSCIENCES

intima-biosciences-logo

Intima Biosciences is a cell therapy business that focuses on solid tumor cancer cures. With its Molecular and Cell Therapy (MCT) GMP gene and cell therapy production facility, Intima Bioscience is undertaking a clinical trial at the University of Minnesota Masonic Cancer Center. It is headquartered in New York City.

#SimilarOrganizations #People #Event #Website #More

INTIMA BIOSCIENCES

Industry:
Biotechnology

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.intimabioscience.com

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Sitelinks Search Box


Similar Organizations

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

Current Employees Featured

campbell-murray_image

Campbell Murray
Campbell Murray President & Chief Operating Officer @ Intima Biosciences
President & Chief Operating Officer
2020-01-01

alessandro-riva_image

Alessandro Riva
Alessandro Riva Chief Executive Officer @ Intima Biosciences
Chief Executive Officer
2021-09-01

Key Employee Changes

Date New article
2021-11-10 Intima Bioscience Appoints Alessandro Riva, M.D., as Chief Executive Officer

Official Site Inspections

http://www.intimabioscience.com Semrush global rank: 4.46 M Semrush visits lastest month: 2.45 K

  • Host name: 104.21.48.127
  • IP address: 104.21.48.127
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Intima Biosciences"

Intima Bioscience

A clinical stage gene and cell therapy company focused on curative intent in solid tumor cancer CHECKPOINT CELL THERAPY THE NEXT GENERATION OF CANCER PLATFORM TECHNOLOGY CISH: a novel immune checkpoint T โ€ฆSee details»

Intima Biosciences - Crunchbase Company Profile

Intima Biosciences is a cell therapy business that focuses on solid tumor cancer cures. With its Molecular and Cell Therapy (MCT) GMP gene and cell therapy โ€ฆSee details»

Intima Bioscience, Inc. - Drug pipelines, Patents, Clinical trials ...

Www.intimabioscience.com. Private Company | 2014 | New York, United States | 10-50 | www.intimabioscience.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. ... He aims to โ€ฆSee details»

Intima Bioscience - LinkedIn

A clinical stage gene and cell therapy company focused on curative intent in solid tumor cancerSee details»

Working at Intima Bioscience - Glassdoor

Glassdoor gives you an inside look at what it's like to work at Intima Bioscience, including salaries, reviews, office photos, and more. This is the Intima Bioscience company profile. All โ€ฆSee details»

Intima Bioscience Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Intima Bioscience Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»

Intima Bioscience - PitchBook

The company's platform specializes in clinical-stage gene and cellular therapies, to assess the safety and efficacy of genetically-engineered, neoantigen-specific tumor-infiltrating โ€ฆSee details»

Intima Bioscience - Overview, News & Similar companies - ZoomInfo

Www.intimabioscience.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview ; Org Chart ; Who is โ€ฆSee details»

Intima Bioscience - Company Profile - Tracxn

Oct 31, 2024 Intima Bioscience aims to develop a gene and cell therapeutic platform for gastrointestinal cancer. The company is under the clinical trial phase and conducting โ€ฆSee details»

Company: Intima Bioscience - CRISPR Medicine

Intima Bioscience is a clinical-stage gene and cell therapy company focused on developing cures for solid cancers. The company develops tumour-infiltrating lymphocytes (TILs) in which the โ€ฆSee details»

Intima Bioscience - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โ€ฆSee details»

Alessandro Riva, M.D. | BeiGene

Alessandro Riva, M.D., joined our Board of Directors in February 2022.. Dr. Riva is Chief Executive Officer of Intima Bioscience, a privately held clinical-stage gene and cell therapy โ€ฆSee details»

Intima Bioscience, Inc. | Insights

Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

Intima Bioscience Appoints Alessandro Riva, M.D., as Chief

Nov 10, 2021 NEW YORK--(BUSINESS WIRE)-- Intima Bioscience, a clinical stage biotechnology company developing genetically engineered cell therapies for solid tumor โ€ฆSee details»

License with Intima Bioscience - MaxCyte Inc

Feb 1, 2022 MaxCyte Signs Strategic Platform License with Intima Bioscience . to Advance Tumor Infiltrating Lymphocytes Programs . Intima Bioscience to use MaxCyte's Flow โ€ฆSee details»

Intima Bioscience poaches ex-Ichnos CEO with Gilead ... - Fierce โ€ฆ

Nov 10, 2021 The pharma and biotech worlds have been a revolving door for Alessandro Riva, M.D., since 2017. Now, he's been poached by a relatively under-the-wraps biotech as its next โ€ฆSee details»

Alessandro Riva - Chairman & CEO at Transgene - The Org

Dr. Riva has nearly 30 yearsโ€™ experience in the Life Sciences industry. He was CEO of Intima Bioscience which specializes in cell therapies for solid cancers and was previously CEO of โ€ฆSee details»

Intima Bioscience Reviews: What Is It Like to Work At ... - Glassdoor

Oct 18, 2023 1 Intima Bioscience reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»

Intima Bioscience Appoints Alessandro Riva, M.D., as Chief โ€ฆ

Nov 10, 2021 Intima Bioscience is a company advancing checkpoint cell therapy, an approach that combines the use of patientsโ€™ own immune cells with immune checkpoint targeting, in โ€ฆSee details»

University of Minnesota, Intima Bioscience Begin Trial of CRISPR โ€ฆ

Oct 13, 2020 NEW YORK โ€“ The University of Minnesota on Monday announced that it had begun enrolling patients in a Phase II clinical trial evaluating a personalized, CRISPR-edited, T โ€ฆSee details»

linkstock.net © 2022. All rights reserved